{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:42:59Z","timestamp":1790667779629,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jpba.2017.07.018","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T16:34:39Z","timestamp":1500741279000},"page":"24-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Validated LC\u2013MS\/MS method for the simultaneous determination of rotigotine and its prodrug in rat plasma and an application to pharmacokinetics and biological conversion in vitro"],"prefix":"10.1016","volume":"146","author":[{"given":"Chunjie","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2017.07.018_bib0005","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40265-015-0377-y","article-title":"An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome","volume":"75","author":"Elshoff","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2017.07.018_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp.62.1.10","article-title":"Prevalence of parkinsonism and Parkinson\u2019s disease in europe: the EUROPARKINSON collaborative study. european community concerted action on the epidemiology of Parkinson\u2019s disease","volume":"62","author":"de Rijk","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jpba.2017.07.018_bib0015","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jpba.2017.07.018_bib0020","first-page":"233","article-title":"Mini Review Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinsons disease","volume":"43","author":"Seol","year":"2010","journal-title":"Biochem. Mol. Biol. Rep."},{"key":"10.1016\/j.jpba.2017.07.018_bib0025","doi-asserted-by":"crossref","first-page":"8730","DOI":"10.1371\/journal.pone.0008730","article-title":"The Parkinson\u2019s disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation","volume":"5","author":"Kumar","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2017.07.018_bib0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(05)70801-1","article-title":"Parkinson\u2019s disease in China: prevalence in Beijing, Xian, and Shanghai","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2017.07.018_bib0035","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneurol.2010.55","article-title":"Restless legs syndrome: pathophysiology: clinical presentation and management","volume":"6","author":"Trenkwalder","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jpba.2017.07.018_bib0040","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archinte.164.2.196","article-title":"Sex and the risk of restless legs syndrome in the general population","volume":"164","author":"Berger","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jpba.2017.07.018_bib0045","unstructured":"http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2015\/021829s007lbl.pdf Neupro\u00ae label."},{"key":"10.1016\/j.jpba.2017.07.018_bib0050","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1021\/jm0303812","article-title":"Lessons learned from marketed and investigational prodrugs","volume":"47","author":"Ettmayer","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jpba.2017.07.018_bib0055","series-title":"Hydrolysis in Drug and Prodrug Metabolisms Chemistry, Biochemistry and Enzymology","author":"Testa","year":"2003"},{"key":"10.1016\/j.jpba.2017.07.018_bib0060","unstructured":"US FDA, US Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD, USA, 2001, http:\/\/www.fda.gov\/downloads\/drugs\/. Guidance compliance regulatory information\/guidances\/ucm070107.pdf."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517311305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517311305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:30:52Z","timestamp":1535578252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517311305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":12,"alternative-id":["S0731708517311305"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.07.018","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validated LC\u2013MS\/MS method for the simultaneous determination of rotigotine and its prodrug in rat plasma and an application to pharmacokinetics and biological conversion in vitro","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}